UC Irvine receives CIRM grant to advance stem cell-based treatments for AD, retinitis pigmentosa
Efforts to begin human clinical trials using stem cells to treat Alzheimer's disease and retinitis pigmentosa received a $37.3 million boost from the California Institute for Regenerative Medicine during its most recent round of funding on Sept. 5.